Corkrean John J 4
4 · FULLER H B CO · Filed May 11, 2026
Research Summary
AI-generated summary of this filing
FULLER H B CO (FUL) CFO John J Corkrean Receives Award
What Happened
John J Corkrean, Executive Vice President and Chief Financial Officer of FULLER H B CO (FUL), was granted 205.77 derivative stock units on May 8, 2026. The award is reported at a grant price of $61.25 per unit, for a total reported value of approximately $12,603. This was an award/grant (not an open-market purchase or sale).
Key Details
- Transaction type: Award/grant of derivative stock units (code A).
- Transaction date: 2026-05-08; Form 4 filed: 2026-05-11 (filed within the required reporting window).
- Quantity and valuation: 205.77 units × $61.25 = $12,603 (reported as derivative).
- Shares owned after transaction: Not disclosed in the excerpt provided.
- Footnotes in the filing indicate these are stock/restricted stock units or deferred-compensation units that generally convert 1-for-1 into common shares, may include dividend-equivalent features, and can be subject to vesting schedules or holding periods.
Context
This was a grant of stock-based units to an executive—not an open-market buy or sale—so it reflects compensation rather than an immediate market bet by the insider. Derivative/unit awards typically convert into common shares per the plan terms and may vest or be subject to deferral/holding rules; check the full Form 4 or company disclosures for exact vesting and conversion rules.
Insider Transaction Report
- Award
Phantom Units
[F1][F2][F3]2026-05-08$61.25/sh+205.77$12,603→ 33,661.41 totalExercise: $0.00→ Common Stock (205.77 underlying)
- 59,508
Common Stock
- 41,208
Employee Stock Option (Right-to-Buy)
[F4]Exercise: $45.05From: 2020-01-24Exp: 2029-01-24→ Common Stock (41,208 underlying) - 48,309
Employee Stock Option (Right-to-Buy)
[F4]Exercise: $48.35From: 2021-01-24Exp: 2030-01-24→ Common Stock (48,309 underlying) - 23,696
Employee Stock Option (Right-to-Buy)
[F4]Exercise: $50.10From: 2018-01-26Exp: 2027-01-26→ Common Stock (23,696 underlying) - 38,376
Employee Stock Option (Right-to-Buy)
[F4]Exercise: $51.89From: 2022-01-27Exp: 2031-01-27→ Common Stock (38,376 underlying) - 21,834
Employee Stock Option (Right-to-Buy)
[F4]Exercise: $53.57From: 2019-01-25Exp: 2028-01-25→ Common Stock (21,834 underlying) - 39,347
Employee Stock Option (Right-to-Buy)
[F5]Exercise: $59.81From: 2027-01-26Exp: 2036-01-26→ Common Stock (39,347 underlying) - 24,570
Employee Stock Option (Right-to-Buy)
[F5]Exercise: $64.28From: 2026-01-27Exp: 2035-01-27→ Common Stock (24,570 underlying) - 22,312
Employee Stock Option (Right-to-Buy)
[F4]Exercise: $68.17From: 2024-01-24Exp: 2033-01-24→ Common Stock (22,312 underlying) - 21,997
Employee Stock Option (Right-to-Buy)
[F4]Exercise: $72.94From: 2023-01-24Exp: 2032-01-24→ Common Stock (21,997 underlying) - 24,774
Employee Stock Option (Right-to-Buy)
[F5]Exercise: $77.72From: 2025-01-26Exp: 2034-01-26→ Common Stock (24,774 underlying) - 1,453.86
Restricted Stock Units
[F6][F7][F8]Exercise: $0.00From: 2025-01-26Exp: 2027-01-26→ Common Stock (1,453.86 underlying) - 5,824.9
Restricted Stock Units
[F6][F7][F8]Exercise: $0.00From: 2027-01-26Exp: 2029-01-26→ Common Stock (5,824.9 underlying) - 2,940.13
Restricted Stock Units
[F6][F7][F8]Exercise: $0.00From: 2026-01-27Exp: 2028-01-27→ Common Stock (2,940.13 underlying)
Footnotes (8)
- [F1]These units (acquired after 12-31-04) convert into shares of common stock on a 1-for-1 basis.
- [F2]These units (acquired after 12-31-04) convert into shares of common stock upon the earlier of certain termination events as specified in the Key Employee Deferred Compensation Plan or such earlier date as selected by the participant, subject to holding periods required by law.
- [F3]Amount includes stock units acquired pursuant to a dividend equivalent feature.
- [F4]This option is 100% vested.
- [F5]This option vests in three annual installments (33%, 33%, and 34%) beginning on the date shown.
- [F6]These restricted stock units convert into shares of common stock on a 1-for-1 basis.
- [F7]These restricted stock units vest in three annual installments (33%, 33%, and 34%) beginning on the date shown.
- [F8]Amount includes restricted stock units acquired pursuant to a dividend equivalent reinvestment feature.